344 related articles for article (PubMed ID: 28822791)
1. Acute unilateral hip pain in fibrodysplasia ossificans progressiva (FOP).
Kaplan FS; Al Mukaddam M; Pignolo RJ
Bone; 2018 Apr; 109():115-119. PubMed ID: 28822791
[TBL] [Abstract][Full Text] [Related]
2. The Natural History of Flare-Ups in Fibrodysplasia Ossificans Progressiva (FOP): A Comprehensive Global Assessment.
Pignolo RJ; Bedford-Gay C; Liljesthröm M; Durbin-Johnson BP; Shore EM; Rocke DM; Kaplan FS
J Bone Miner Res; 2016 Mar; 31(3):650-6. PubMed ID: 27025942
[TBL] [Abstract][Full Text] [Related]
3. Most Fractures Treated Nonoperatively in Individuals With Fibrodysplasia Ossificans Progressiva Heal With a Paucity of Flareups, Heterotopic Ossification, and Loss of Mobility.
Lindborg CM; Al Mukaddam M; Baujat G; Cho TJ; De Cunto CL; Delai PLR; Eekhoff EMW; Haga N; Hsiao EC; Morhart R; de Ruiter R; Scott C; Seemann P; Szczepanek M; Tabarkiewicz J; Pignolo RJ; Kaplan FS
Clin Orthop Relat Res; 2023 Dec; 481(12):2447-2458. PubMed ID: 37156007
[TBL] [Abstract][Full Text] [Related]
4. Skeletal malformations and developmental arthropathy in individuals who have fibrodysplasia ossificans progressiva.
Towler OW; Shore EM; Kaplan FS
Bone; 2020 Jan; 130():115116. PubMed ID: 31655222
[TBL] [Abstract][Full Text] [Related]
5. Natural history of fibrodysplasia ossificans progressiva: cross-sectional analysis of annotated baseline phenotypes.
Pignolo RJ; Baujat G; Brown MA; De Cunto C; Di Rocco M; Hsiao EC; Keen R; Al Mukaddam M; Sang KLQ; Wilson A; White B; Grogan DR; Kaplan FS
Orphanet J Rare Dis; 2019 May; 14(1):98. PubMed ID: 31053156
[TBL] [Abstract][Full Text] [Related]
6. Surgical management of bilateral hip fractures in a patient with fibrodysplasia ossificans progressiva treated with the RAR-γ agonist palovarotene: a case report.
Singh S; Kidane J; Wentworth KL; Motamedi D; Morshed S; Schober AE; Hsiao EC
BMC Musculoskelet Disord; 2020 Apr; 21(1):204. PubMed ID: 32245464
[TBL] [Abstract][Full Text] [Related]
7. Imaging assessment of fibrodysplasia ossificans progressiva: Qualitative, quantitative and questionable.
Al Mukaddam M; Rajapakse CS; Pignolo RJ; Kaplan FS; Smith SE
Bone; 2018 Apr; 109():147-152. PubMed ID: 28822792
[TBL] [Abstract][Full Text] [Related]
8. Fibrodysplasia ossificans progressiva: clinical and genetic aspects.
Pignolo RJ; Shore EM; Kaplan FS
Orphanet J Rare Dis; 2011 Dec; 6():80. PubMed ID: 22133093
[TBL] [Abstract][Full Text] [Related]
9. Joint-specific risk of impaired function in fibrodysplasia ossificans progressiva (FOP).
Pignolo RJ; Durbin-Johnson BP; Rocke DM; Kaplan FS
Bone; 2018 Apr; 109():124-133. PubMed ID: 28627475
[TBL] [Abstract][Full Text] [Related]
10. Fibrodysplasia Ossificans Progressiva: A Challenging Diagnosis.
De Brasi D; Orlando F; Gaeta V; De Liso M; Acquaviva F; Martemucci L; Mastrominico A; Di Rocco M
Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440363
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal patient-reported mobility assessment in fibrodysplasia ossificans progressiva (FOP).
Kaplan FS; Al Mukaddam M; Pignolo RJ
Bone; 2018 Apr; 109():158-161. PubMed ID: 28600150
[TBL] [Abstract][Full Text] [Related]
12. Fibrodysplasia ossificans progressiva (stone man syndrome): a case report.
Shah ZA; Rausch S; Arif U; El Yafawi B
J Med Case Rep; 2019 Dec; 13(1):364. PubMed ID: 31785620
[TBL] [Abstract][Full Text] [Related]
13. A cumulative analogue joint involvement scale (CAJIS) for fibrodysplasia ossificans progressiva (FOP).
Kaplan FS; Al Mukaddam M; Pignolo RJ
Bone; 2017 Aug; 101():123-128. PubMed ID: 28465250
[TBL] [Abstract][Full Text] [Related]
14. The serum levels of activin A and bone morphogenetic protein-4 and -6 in patients with fibrodysplasia ossificans progressiva.
Ye Z; Wang S; Shan C; Zhu Q; Xue Y; Zhang K
Orphanet J Rare Dis; 2023 May; 18(1):111. PubMed ID: 37165433
[TBL] [Abstract][Full Text] [Related]
15. Early diagnosis of fibrodysplasia ossificans progressiva.
Kaplan FS; Xu M; Glaser DL; Collins F; Connor M; Kitterman J; Sillence D; Zackai E; Ravitsky V; Zasloff M; Ganguly A; Shore EM
Pediatrics; 2008 May; 121(5):e1295-300. PubMed ID: 18450872
[TBL] [Abstract][Full Text] [Related]
16. The natural history of fibrodysplasia ossificans progressiva: A prospective, global 36-month study.
Pignolo RJ; Baujat G; Brown MA; De Cunto C; Hsiao EC; Keen R; Al Mukaddam M; Le Quan Sang KH; Wilson A; Marino R; Strahs A; Kaplan FS
Genet Med; 2022 Dec; 24(12):2422-2433. PubMed ID: 36152026
[TBL] [Abstract][Full Text] [Related]
17. [18F]NaF PET/CT scan as an early marker of heterotopic ossification in fibrodysplasia ossificans progressiva.
Eekhoff EMW; Botman E; Coen Netelenbos J; de Graaf P; Bravenboer N; Micha D; Pals G; de Vries TJ; Schoenmaker T; Hoebink M; Lammertsma AA; Raijmakers PGHM
Bone; 2018 Apr; 109():143-146. PubMed ID: 28826841
[TBL] [Abstract][Full Text] [Related]
18. Early clinical observations on the use of imatinib mesylate in FOP: A report of seven cases.
Kaplan FS; Andolina JR; Adamson PC; Teachey DT; Finklestein JZ; Ebb DH; Whitehead B; Jacobs B; Siegel DM; Keen R; Hsiao E; Pignolo RJ
Bone; 2018 Apr; 109():276-280. PubMed ID: 28736245
[TBL] [Abstract][Full Text] [Related]
19. An mTOR Signaling Modulator Suppressed Heterotopic Ossification of Fibrodysplasia Ossificans Progressiva.
Hino K; Zhao C; Horigome K; Nishio M; Okanishi Y; Nagata S; Komura S; Yamada Y; Toguchida J; Ohta A; Ikeya M
Stem Cell Reports; 2018 Nov; 11(5):1106-1119. PubMed ID: 30392977
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
